HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $462.6364.
HCA has been the topic of several recent research reports. Oppenheimer reduced their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Truist Financial reduced their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 14th. Robert W. Baird lowered their price target on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Finally, Mizuho decreased their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a report on Tuesday, July 28th.
Hedge Funds Weigh In On HCA Healthcare
HCA Healthcare Trading Down 0.3%
Shares of NYSE:HCA opened at $413.02 on Friday. HCA Healthcare has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a market cap of $89.42 billion, a P/E ratio of 13.83, a P/E/G ratio of 1.44 and a beta of 1.10. The company has a 50 day moving average of $402.35 and a 200 day moving average of $439.62.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the prior year, the company earned $6.84 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts forecast that HCA Healthcare will post 29.42 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
